Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-007237-47Phase 4Terminated
A Phase 4 trial of physostigmine in delirium, post-operative cognitive decline (POCD), sponsored by Charité – Universitätsmedizin Berlin. Started Nov 2008; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-007237-47.